Taiwan Advance Bio-Pharmaceutical (ROCO:4186) Scaled Net Operating Assets : 0.52 (As of Dec. 2023)

Taiwan Advance Bio-Pharmaceutical Scaled Net Operating Assets Chart

Taiwan Advance Bio-Pharmaceutical Annual Data
	Trend	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
Scaled Net Operating Assets		Get a 7-Day Free Trial					0.63	0.61	0.41	0.53	0.53

Taiwan Advance Bio-Pharmaceutical Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Scaled Net Operating Assets	Get a 7-Day Free Trial															0.52	0.53	0.56	0.53	0.52

Competitive Comparison of Taiwan Advance Bio-Pharmaceutical's Scaled Net Operating Assets

For the Biotechnology subindustry, Taiwan Advance Bio-Pharmaceutical's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Taiwan Advance Bio-Pharmaceutical's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Taiwan Advance Bio-Pharmaceutical's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Taiwan Advance Bio-Pharmaceutical's Scaled Net Operating Assets falls into.

Taiwan Advance Bio-Pharmaceutical Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Taiwan Advance Bio-Pharmaceutical's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

where

Taiwan Advance Bio-Pharmaceutical's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2023 is calculated as

where

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Taiwan Advance Bio-Pharmaceutical Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Taiwan Advance Bio-Pharmaceutical's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Taiwan Advance Bio-Pharmaceutical (ROCO:4186) Business Description